An independent source of information on U.S. brand name drugs for health professionals

Drugdocs Logo

An independent source of information on U.S. brand name drugs for health professionals

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Aristada

Chemical Namearipiprazole lauroxil
Dosage FormExtended-release injectable suspension (intramuscular; 441 mg, 662 mg, 882 mg, 1064 mg)
Drug ClassAntipsychotics
SystemNervous
CompanyAlkermes Inc
Approval Year2015

Indication

  • To treat adults with schizophrenia.
Last updated on 10/9/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Aristada (aripiprazole lauroxil) Prescribing Information2020Alkermes, Inc., Waltham, MA
Document TitleYearSource
Efficacy and safety of aripiprazole lauroxil once-monthly versus aripiprazole once-monthly long-acting injectable formulations in patients with acute symptoms of schizophrenia: an indirect comparison of two double-blind placebo-controlled studies.2018Current Medical Research and Opinion